New Options in Eradication of Helicobacter pylori

References

• Graham D Y, Lew G M, Evans D G, Evans D J, Klein P D. Effect of triple therapy (Antibiotics plus Bismuth) on duodenal ulcer healing. Ann Intern Med 1991; 115: 266–9
   PubMed Web of Science ®Google Scholar
• Seppälä K, Pikkarainen P, Karvonen A L, Gormsen M, and the FGUSG. The role of Helicobacter pylori (Hp) eradication in gastric ulcer healing and relapses. Gastroenterology 1992; 102: A262
   Google Scholar
• Hosking S W, Ling T KW, Chung S CS, et al. Duodenal ulcer healing by eradication of H. pylori without anti-acid treatment: randomized controlled trial. Lancet 1994; 343: 508–10
   PubMed Web of Science ®Google Scholar
• Sung J JY, Chung S CS, Ling T KW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139–42
   PubMed Web of Science ®Google Scholar
• Börsch G, Mai U, Opferkuch W. Oral triple therapy (OTT) may effectively eradicate Campylobacter pylori (C.P.) in man: a pilot study. Gastroenterology 1988; 94: A44
   Web of Science ®Google Scholar
• Borody T, Cole P, Noonan S, et al. Long-term Campylobacter pylori recurrence post-eradication. Gastroenterology 1988; 94: A43
   Web of Science ®Google Scholar
• Tytgat G NJ, Noach L A. H. pylori eradication. Helicobacter pylori: Basic Mechanisms to Clinical Cure, R H Hunt, G NJ Tytgat. Kluwer Academic Publishers, Dordrecht 1994; 550–69
   Google Scholar
• Rautelin H, Seppälä K, Renkonen O V, Vainio U, Kosunen T U. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992; 36: 163–6
   PubMed Web of Science ®Google Scholar
• Xla H, Daw M A, Sant S, Beattie S, Keane C T, O'Morain C. Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer. Eur J Gastroenterol Hepatol 1993; 5: 141–4
   Web of Science ®Google Scholar
• Tytgat G NJ. Review article: treatments that impact favourable upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359–68
   PubMed Web of Science ®Google Scholar
• Logan R PH, Gummett P A, Misiewicz Karim QN, Walker M M, Baron J H. One week eradication regimen of Helicobacter pylori. Lancet 1991; 338: 1249–52
   PubMed Web of Science ®Google Scholar
• Banatvala N, Davies G R, Abdi Y, et al. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 1994; 35: 1562–6
   PubMed Web of Science ®Google Scholar
• Glupczynski Y, Burette A, DeKoster E, et al. Metronidazole resistance in Helicobacter pylori (Letter). Lancet 1990; 335: 976–7
   PubMed Web of Science ®Google Scholar
• Tham T CK, Collins J SA, McCormick C, Sloan J M, Bamford K, Watson R GP. Ranitidine and omeprazole and their combination with antibiotics in the eradication of Helicobacter pylori: a randomized controlled trial. Gut 1995; 37(Suppl 1)A55
   Google Scholar
• Marshall B J. Treatment of Helicobacter pylori. Helicobacter pylori in Peptic Ulceration and Gastritis, B J Marshall, R W McCallum, R L Guerrant. Blackwell Scientific Publications, Oxford 1991; 160–86
   Google Scholar
• Axon A TR. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastroenterol Hepatol 1991; 6: 131–7
   PubMed Web of Science ®Google Scholar
• Marshall B J, Guerrant R L, Hoffman S R, Barrett L, McCallum R W. Eradication of metronidazole resistant H. pylori. Am J Gastroenterol 1991; 86: 1315
   Google Scholar
• Borody T J, Brandl S, Andrews S, Jankiewicz E, Ostapowicz. H. pylori eradication failure (EF) — further treatment possibilities. Gastroenterology 1992; 102: A163
   PubMedGoogle Scholar
• Seppälä K, Sipponen P, Nuutinen H, Färkkilä M, Anisimova S, Kosunen T U. Intent to treat eradication failures with metronidazole resistant H. pylori infection to 100% cure. Therapy with quadruple therapy and its modifications. Gastroenterology 1995; 108: A216
   Google Scholar
• Hosking S W, Ling T KW, Yung M Y, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ 1992; 305: 502–4
   PubMed Web of Science ®Google Scholar
• Borody T J, Brandl S, Andrews P, Ostapowicz N, Jankiewicz E. High efficacy, low dose triple therapy (TT) for Helicobacter pylori HP. Gastroenterology 1992; 102: A162
   Google Scholar
• Westblom U T, Duriex D E. Enhancement of antibiotic concentrations in gastric mucosa by H2-reseptor antagonist. Dig Dis Sci 1991; 36: 25–8
   PubMed Web of Science ®Google Scholar
• Hentschel E, Brandstätter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308–12
   PubMed Web of Science ®Google Scholar
• de Boer W A, Driessen W AA, Potters V PJ, Tytgat G NJ. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994; 89: 1993–7
   PubMed Web of Science ®Google Scholar
• Borody T J, Andrews P, Shortis N P, Bae H, Brandl S. Optimal H. pylori (HP) therapy — a combination of omeprazole and triple therapy (TT). Gastroenterology 1994; 106: A55
   Web of Science ®Google Scholar
• Lambert J R, Arena G. Mucosal antibiotic levels. Helicobacter pylori: Basic Mechanisms to Clinical Cure, R H Hunt, G NJ Tytgat. Kluwer Academic Publishers, Dordrecht 1994; 538–49
   Google Scholar
• Goodwin C S, McNulty C AM. Bacteriological and pharmacological basis for the treatment of Helicobacter pylori infection. Helicobacter pylori and Gastroduodenal Disease, B J Rathbone, R V Heatley. Blackwell Scientific Publications, Oxford 1992; 224–30
   Google Scholar
• Goddard A, Logan R. One week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995; 7: 1–3
   PubMed Web of Science ®Google Scholar
• Bell G D, Powell K U, Burridge S M, et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med 1993; 86: 743–50
   PubMedGoogle Scholar
• Bell G D, Powell K U, Burridge S M, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 41–6
   PubMed Web of Science ®Google Scholar
• de Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancer 1995; 345: 817–20
   PubMed Web of Science ®Google Scholar
• Borody T J, Andrews P, Shortis N P, Hyland L. 7 day therapy for H. pylori. Gastroenterology 1995; 107: A910
   Google Scholar
• Bazzoll F, Zagarl R M, Fossl S, et al. Short term low dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773–7
   Web of Science ®Google Scholar
• Labenz J, Stolte M, Ruhl G H. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995; 7: 9–11
   PubMed Web of Science ®Google Scholar
• Lind T, Veldhuyzen van Zanten S JO, Unge P, et al. The MACH 1 study: optimal one-week treatment for H. pylori defined?. Gut 1995; 37(Suppl 1)A4
   PubMedGoogle Scholar
• Moayyedl P, Tompkins D S, Axon A TR. Determination of the optimum dose of omeprazole in a new triple therapy regimen for eradicating Helicobacter pylori. Gut 1994; 35(Suppl 5)W63
   Google Scholar
• Buckley M, Xia H X, Hyde D, O'Morain C. A cost-effective, European approach to H. pylori eradication. Gut 1995; 37(Suppl 1)A91
   PubMedGoogle Scholar
• Jaup B H, Norrby A. Low dose short term triple therapy for eradication of Helicobacter pylori. Am J Gastroenterol 1994; 89: 1400
   Web of Science ®Google Scholar
• Pounder R E. Treatment of peptic ulcers now to the millenium. Baillieres Clinical Gastroenterol 1994; 8: 339–50
   PubMedGoogle Scholar
• Wyeth J W, Pounder R E, DeKoster E, et al. GR122311X (Ranitidine bismuth citrate) with antibiotics for the eradication of Helicobacter pylori. Gastroenterology 1994; 2217
   Web of Science ®Google Scholar
• Butruk E, Ching C K, Shütze K, Duggan A E. GR122311X (Ranitidin bismuth citrate) with amoxicillin for treatment of duodenal ulcer. Gastroenterology 1995; 108: A64
   Web of Science ®Google Scholar
• Bardhan K D, Dallalre C, Eisold H, Duggan A E. The treatment of duodenal ulcer with GR122311X (Ranitidine bismuth citrate) and clarithromycin. Gut 1995; 37(Suppl 1)A5
   Google Scholar
• Pounder R E, Bailey R, Louw J A, et al. GR122311X (Ranitidine bismuth citrate) with clarithromycin for the eradication of Helicobacter pylori. Gut 1995; 37(Suppl 1)A42
   Google Scholar
• Kimura K, Ido K, Saifuku K, et al. One-hour topical therapy for the eradication of H. pylori. Am J Gastroenterol 1994; 89: 1403
   Google Scholar